Susumu Imaoka
- Molecular Biology top 2%
- Pharmacology top 0.02%
- Oncology top 1%
- Biochemistry top 0.1%
- Cancer Research top 1%
- Co-authors
- Yoshihiko FunaeToyoko HiroiAmi OguroHideo InajiKazuyoshi MotomuraY FunaeMasao KameyamaTomohiko Aihara
- Topics
- Pharmacogenetics and Drug Metabolism (103 papers)Eicosanoids and Hypertension Pharmacology (50 papers)Drug Transport and Resistance Mechanisms (41 papers)
- Cited by
- PharmacologyBiochemistryOncology
- Partner nations
- JapanUnited StatesCzechia
In The Last Decade
Susumu Imaoka
300 papers receiving 9.0k citations
Peers
Comparison fields: 5 of 145
- Molecular Biology 3.1k
- Pharmacology 2.9k
- Oncology 2.3k
- Biochemistry 1.3k
- Cancer Research 1.2k
Countries citing papers authored by Susumu Imaoka
This map shows the geographic impact of Susumu Imaoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susumu Imaoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susumu Imaoka more than expected).
Fields of papers citing papers by Susumu Imaoka
This network shows the impact of papers produced by Susumu Imaoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susumu Imaoka. The network helps show where Susumu Imaoka may publish in the future.
Co-authorship network of co-authors of Susumu Imaoka
This figure shows the co-authorship network connecting the top 25 collaborators of Susumu Imaoka. A scholar is included among the top collaborators of Susumu Imaoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susumu Imaoka. Susumu Imaoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 10 | |
| 3 | A 45 nm Low-Standby-Power Embedded SRAM with Improved Immunity Against Process and Temperature Variations | 3 |
| 4 | 5 | |
| 5 | A 65 nm SoC Embedded 6T-SRAM Design for Manufacturing with Read and Write Cell Stabilizing Circuits | 2 |
| 6 | A 65 nm Ultra-High-Density Dual-port SRAM with 0.71um2 8T-cell for SoC | 3 |
| 7 | 35 | |
| 8 | Inhibitory effects of environmental chemicals on protein disulfide isomerase in vitro. | 9 |
| 9 | 51 | |
| 10 | 136 | |
| 11 | Minute carcinoma of the pancreas measuring 1 cm or less in diameter--collective review of Japanese case reports. | 87 |
| 12 | 15 | |
| 13 | 13 | |
| 14 | 174 | |
| 15 | 237 | |
| 16 | 33 | |
| 17 | 34 | |
| 18 | 310 TRIMETHADIONE METABOLISM BY HEPATIC CYTOCHROMR P-450s PURIFIED FROM RATS AND HUMANS | 2 |
| 19 | 127 | |
| 20 | [A case of colorectal cancer showing complete response to UFT]. | 1 |
About Susumu Imaoka
Susumu Imaoka is a scholar working on Pharmacology, Biochemistry and Hepatology, having authored 303 papers that have together received 9.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (103 papers), Eicosanoids and Hypertension Pharmacology (50 papers) and Drug Transport and Resistance Mechanisms (41 papers). The work is most often cited by research in Pharmacology (2.9k citations), Biochemistry (1.3k citations) and Oncology (2.3k citations). Susumu Imaoka has collaborated with scholars based in Japan, United States and Czechia. Frequent co-authors include Yoshihiko Funae, Toyoko Hiroi, Ami Oguro, Hideo Inaji, Kazuyoshi Motomura, Y Funae, Masao Kameyama, Tomohiko Aihara, Mayuko Osada and Yo Sasaki. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.